HOLOGIC INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-08: Form 8-K; Period of report 2023-12-06; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 5.02.
- 2023-11-13: Form 8-K; Period of report 2023-11-06; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2023-11-09: Form 8-K; Period of report 2023-11-09; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2023-09-22: Form 8-K; Period of report 2023-09-20; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2023-12-08 | 8-K | 2023-12-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 (c) Essex D. Mitchell. 8.01 As a result of Mr. Mitchell’s promotion, Brandon Schnittker, currently Vice President, Surgical Sales, will assume the role of Division President, GYN Surgical Solutions, effective January 1, 2024. | a53868116.htm |
| 2023-11-13 | 8-K | 2023-11-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Approval of revised forms of Performance Stock Unit (“PSU”) Award Agreements. | d502909d8k.htm |
| 2023-11-09 | 8-K | 2023-11-09 | 2.02 Results of Operations and Financial Condition | 2.02 On November 9, 2023, Hologic, Inc. issued a press release announcing its financial results for the fourth quarter and year ended September 30, 2023. | a53797393.htm |
| 2023-09-22 | 8-K | 2023-09-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 20, 2023, the Board of Directors (the “Board”) of Hologic, Inc. (the “Company”), upon the recommendation of the Company’s Nominating and Corporate Governance Committee, increased the size of the Board from nine to ten directors and appointed Nanaz Mohtashami as a director of the Company, effective September 20, 2023. | a53559220.htm |
| 2023-07-31 | 8-K | 2023-07-31 | 2.02 Results of Operations and Financial Condition | 2.02 On July 31, 2023, Hologic, Inc. issued a press release announcing its financial results for the third quarter ended July 1, 2023. | a53490141.htm |
| 2023-05-01 | 8-K | 2023-05-01 | 2.02 Results of Operations and Financial Condition | 2.02 On May 1, 2023, Hologic, Inc. issued a press release announcing its financial results for the second quarter ended April 1, 2023. | a53389994.htm |
| 2023-04-19 | 8-K | 2023-04-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On April 17, 2023, Kevin R. Thornal, Group President, Global Diagnostics Solutions, of Hologic, Inc. (“Hologic” or the “Company”) tendered his resignation from the Company, effective April 21, 2023. 8.01 As a result of Mr. Thornal’s departure, Jennifer Schneiders, Ph.D., currently Vice President, US Sales and Commercial Excellence for the Company’s Diagnostics Solutions Division, will assume the role of President, Diagnostics Solutions, effective April 21, 2023. | d482269d8k.htm |
| 2023-03-10 | 8-K | 2023-03-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 (e) Material Amendment to Compensatory Plan. 5.07 The Company’s Annual Meeting of Stockholders was held on March 9, 2023. | holx-20230309.htm |
| 2023-02-01 | 8-K | 2023-02-01 | 2.02 Results of Operations and Financial Condition | 2.02 On February 1, 2023, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 31, 2022. | a53296357.htm |
| 2023-01-09 | 8-K | 2023-01-08 | 2.02 Results of Operations and Financial Condition | 2.02 On January 8, 2023, Hologic, Inc. issued a press release announcing its preliminary revenue results for the first quarter ended December 31, 2022. | a53178442.htm |